[DOI] [Google Scholar] 258.Han Y., Liu W., Chen L., Xin X., Wang Q., Zhang X., Jin M., Gao Z., Huang W
According to clinical trial results, users of tirzepatide had nearly a threefold higher risk of gastrointestinal issues, while users of semaglutide had less than a twofold higher risk compared to those receiving a placebo
This happens because your body adapts to a lower calorie intake, your energy needs decrease as you lose weight, and factors like protein intake, sleep quality, stress, bowel regularity, and overall diet consistency start to play a larger role in your metabolic response
Trying to get a bargain on your GLP-1 medication might come with some added danger
Some of my favorite moments are with first-time filler patients
3 Throughout the 1900s, further understanding about the disease was established, including its hereditary nature